Department of Oncology, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing 312000, China.
Department of Basic Medicine, Shaoxing University School of Medicine, Shaoxing 312000, China.
Pathol Res Pract. 2023 Apr;244:154389. doi: 10.1016/j.prp.2023.154389. Epub 2023 Feb 27.
Tumor metastasis is a fundamental reason for the poor prognosis of colorectal cancer (CRC) patients. Publications suggested that upregulated Aquaporin-11 (AQP11) can improve CRC patients' prognoses, but few articles investigated the regulation of AQP11 in CRC cell adhesion and hepatic metastases. Therefore, this study will explore the regulatory mechanism of AQP11 regulating CRC cell adhesion and hepatic metastases at the molecular level.
AQP11 and miR-152-3p expression were analyzed based on The Cancer Genome Atlas-Colon Adenocarcinoma/Rectum Adenocarcinoma (TCGA-COAD/READ) dataset and several other datasets. The upstream genes of AQP11 were predicted via StarBase and MicroRNA Data Integration Portal (mirDIP) databases. The signaling pathways in which the downregulated AQP11 enriched were analyzed via Gene Set Enrichment Analysis (GSEA). Cell proliferation, migration, invasion, and adhesion were respectively tested via western blot, Transwell, and cell adhesion assays. The expression of adhesion-related proteins was determined via enzyme-linked immunosorbent assay (ELISA). AQP11 protein level was examined via western blot, and AQP11 functions were validated via nude mice xenograft experiment.
AQP11 was downregulated in CRC, and the upregulated AQP11 remarkably repressed cell proliferation, migration, invasion, and adhesion. The silenced AQP11 notably facilitated the above cell functions in CRC. In addition, AQP11 was negatively regulated by miR-152-3p. In vitro cellular assays revealed that miR-152-3p, by targeting AQP11, facilitated CRC cell proliferation, migration, invasion, and adhesion. An in vivo assay suggested that AQP11 could notably repress CRC growth and metastasis.
The above results confirmed that miR-152-3p/AQP11 axis could regulate CRC hepatic metastases and would be a promising target in anti-cancer treatment.
肿瘤转移是结直肠癌(CRC)患者预后不良的根本原因。有文献表明,上调水通道蛋白 11(AQP11)可以改善 CRC 患者的预后,但很少有文章研究 AQP11 在 CRC 细胞黏附和肝转移中的调节作用。因此,本研究将从分子水平探讨 AQP11 调节 CRC 细胞黏附和肝转移的调控机制。
基于癌症基因组图谱-结肠腺癌/直肠腺癌(TCGA-COAD/READ)数据集和其他几个数据集分析 AQP11 和 miR-152-3p 的表达。通过 StarBase 和 MicroRNA Data Integration Portal(mirDIP)数据库预测 AQP11 的上游基因。通过基因集富集分析(GSEA)分析下调 AQP11 富集的信号通路。通过 Western blot、Transwell 和细胞黏附实验分别检测细胞增殖、迁移、侵袭和黏附。通过酶联免疫吸附试验(ELISA)测定黏附相关蛋白的表达。通过 Western blot 检测 AQP11 蛋白水平,并通过裸鼠异种移植实验验证 AQP11 功能。
AQP11 在 CRC 中下调,上调的 AQP11 显著抑制细胞增殖、迁移、侵袭和黏附。沉默的 AQP11 明显促进了 CRC 中的上述细胞功能。此外,AQP11 受 miR-152-3p 的负调控。体外细胞实验表明,miR-152-3p 通过靶向 AQP11 促进 CRC 细胞增殖、迁移、侵袭和黏附。体内实验表明,AQP11 可显著抑制 CRC 生长和转移。
上述结果证实,miR-152-3p/AQP11 轴可调节 CRC 肝转移,有望成为抗癌治疗的新靶点。